Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents

Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents'. Together they form a unique fingerprint.

Medicine & Life Sciences